Genprex GNPX
NASDAQ GNPX
$2.30 +0.01 (+0.44%)
As of: Nov 12, 2026 · 9:30 AM EST

Genprex (GNPX) Return on Capital Employed [ROCE] (2017 - 2026)

Updated

Genprex's Return on Capital Employed [ROCE] was -593.72% in Q1 2025, down 237.89 percentage points from -355.83% a year earlier but up 807.04 percentage points from the prior quarter.

Analysis

Genprex (GNPX) Return on Capital Employed [ROCE] (2017 - 2026) Analysis & Trends

For FY2024, Return on Capital Employed [ROCE] at Genprex came in at -432.72%, down 220.34 percentage points from FY2023.

  • Return on Capital Employed [ROCE] has now declined for three consecutive years, with a five-year change of -251.38 percentage points (FY2019 to FY2024).
  • In earlier years, Return on Capital Employed [ROCE] was -212.38% in FY2023 (-135.90 pp), -76.47% in FY2022 (-18.29 pp), -58.18% in FY2021 (+47.48 pp) and -105.66% in FY2020 (+75.69 pp).
  • Quarterly Return on Capital Employed [ROCE] has moved between -1400.76% (Q4 2024) and -35.43% (Q2 2021) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] has declined for 13 straight quarters, with an average year-over-year change of -341.04 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q4 2020 (a gain of 257.89 percentage points); the worst was Q4 2024 (a drop of 1102.21 percentage points).
  • Per Business Quant data, GNPX's Return on Capital Employed [ROCE] in the three quarters before Q1 2025 was -1400.76% (Q4 2024), -756.75% (Q3 2024) and -358.60% (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Genprex 988,908.54 -41.15 Mn -423,306.00 -96.72%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -96.72%
Mar 31, 2026 -135.03%
Dec 31, 2025 -331.10%
Sep 30, 2025 -1,428.54%
Jun 30, 2025 -697.35%
Mar 31, 2025 -654.55%
Dec 31, 2024 -1,400.76%
Sep 30, 2024 -756.75%
Jun 30, 2024 -358.60%
Mar 31, 2024 -355.83%
Dec 31, 2023 -298.54%
Sep 30, 2023 -265.24%
Jun 30, 2023 -190.74%
Mar 31, 2023 -143.46%
Dec 31, 2022 -96.46%
Sep 30, 2022 -80.55%
Jun 30, 2022 -61.07%
Mar 31, 2022 -50.29%
Dec 31, 2021 -45.31%
Sep 30, 2021 -38.75%
API Access

Genprex Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=GNPX&period=max&api_key=YOUR_API_KEY